Tesamorelin
GHRH analog specifically engineered for targeted visceral fat reduction. FDA-approved for HIV-related lipodystrophy with strong evidence for abdominal fat reduction and growth hormone restoration.
About Tesamorelin
GHRH analog specifically engineered for targeted visceral fat reduction. FDA-approved for HIV-related lipodystrophy with strong evidence for abdominal fat reduction and growth hormone restoration.
This product is strictly for research purposes only and is not intended for human consumption. It has not been evaluated by the FDA or any equivalent regulatory body. By purchasing this product, you confirm that you understand and acknowledge the research-only nature of this compound, that you are a qualified researcher, and that it will not be used for human administration. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
